Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Medical | 2 | 2024 | 287 | 1.240 |
Why?
|
| Students, Medical | 2 | 2024 | 358 | 1.160 |
Why?
|
| Biological Therapy | 1 | 2021 | 20 | 0.720 |
Why?
|
| Drug Labeling | 1 | 2020 | 27 | 0.680 |
Why?
|
| Fluoroquinolones | 1 | 2020 | 93 | 0.650 |
Why?
|
| Antimicrobial Stewardship | 1 | 2020 | 84 | 0.610 |
Why?
|
| Bacterial Infections | 1 | 2020 | 310 | 0.550 |
Why?
|
| Ambulatory Care | 1 | 2020 | 385 | 0.540 |
Why?
|
| Mass Screening | 1 | 2021 | 781 | 0.480 |
Why?
|
| Mannans | 1 | 2014 | 11 | 0.450 |
Why?
|
| beta-Glucans | 1 | 2014 | 19 | 0.450 |
Why?
|
| Lung Diseases, Fungal | 1 | 2014 | 31 | 0.450 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 726 | 0.440 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2014 | 149 | 0.440 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 2420 | 0.390 |
Why?
|
| Professional Misconduct | 1 | 2024 | 35 | 0.220 |
Why?
|
| Faculty | 1 | 2024 | 100 | 0.210 |
Why?
|
| Burnout, Professional | 1 | 2024 | 117 | 0.190 |
Why?
|
| Polyendocrinopathies, Autoimmune | 1 | 2021 | 5 | 0.180 |
Why?
|
| Problem-Based Learning | 1 | 2021 | 71 | 0.180 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2021 | 46 | 0.180 |
Why?
|
| Learning | 1 | 2024 | 360 | 0.170 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2020 | 24 | 0.170 |
Why?
|
| Bronchitis | 1 | 2020 | 34 | 0.170 |
Why?
|
| Drug Utilization | 1 | 2020 | 160 | 0.160 |
Why?
|
| Sinusitis | 1 | 2020 | 116 | 0.160 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 221 | 0.150 |
Why?
|
| Gliotoxin | 1 | 2017 | 1 | 0.150 |
Why?
|
| Aspergillus | 1 | 2017 | 26 | 0.140 |
Why?
|
| Aspergillosis | 1 | 2017 | 43 | 0.140 |
Why?
|
| Physicians | 1 | 2024 | 581 | 0.140 |
Why?
|
| STAT1 Transcription Factor | 1 | 2017 | 72 | 0.140 |
Why?
|
| Gain of Function Mutation | 1 | 2017 | 105 | 0.130 |
Why?
|
| Ubiquitin | 1 | 2017 | 141 | 0.130 |
Why?
|
| Curriculum | 1 | 2021 | 725 | 0.130 |
Why?
|
| Urinary Tract Infections | 1 | 2020 | 301 | 0.130 |
Why?
|
| Central Nervous System Infections | 1 | 2015 | 21 | 0.130 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2015 | 43 | 0.130 |
Why?
|
| Neutrophil Infiltration | 1 | 2015 | 64 | 0.120 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 251 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2020 | 1173 | 0.120 |
Why?
|
| Candidiasis | 1 | 2015 | 128 | 0.120 |
Why?
|
| Scopulariopsis | 1 | 2014 | 1 | 0.120 |
Why?
|
| Humans | 9 | 2024 | 124143 | 0.120 |
Why?
|
| Paecilomyces | 1 | 2014 | 4 | 0.110 |
Why?
|
| Fusariosis | 1 | 2014 | 3 | 0.110 |
Why?
|
| Invasive Pulmonary Aspergillosis | 1 | 2014 | 2 | 0.110 |
Why?
|
| Galactose | 1 | 2014 | 54 | 0.110 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2014 | 36 | 0.110 |
Why?
|
| Mucormycosis | 1 | 2014 | 27 | 0.110 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2015 | 205 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2024 | 1178 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2020 | 3430 | 0.090 |
Why?
|
| Time Factors | 1 | 2020 | 6281 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2020 | 16273 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 2041 | 0.080 |
Why?
|
| Risk Factors | 2 | 2020 | 10244 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2863 | 0.070 |
Why?
|
| United States | 1 | 2020 | 10855 | 0.060 |
Why?
|
| Mutation | 1 | 2017 | 5818 | 0.050 |
Why?
|
| Americas | 1 | 2021 | 50 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2017 | 3720 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2021 | 434 | 0.040 |
Why?
|
| Candidiasis, Chronic Mucocutaneous | 1 | 2017 | 5 | 0.040 |
Why?
|
| SUMO-1 Protein | 1 | 2017 | 8 | 0.040 |
Why?
|
| Pulmonary Aspergillosis | 1 | 2017 | 9 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 791 | 0.040 |
Why?
|
| Sumoylation | 1 | 2017 | 35 | 0.030 |
Why?
|
| COS Cells | 1 | 2017 | 275 | 0.030 |
Why?
|
| Biopsy | 1 | 2021 | 1237 | 0.030 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2017 | 66 | 0.030 |
Why?
|
| Steroids | 1 | 2017 | 203 | 0.030 |
Why?
|
| Pandemics | 1 | 2024 | 1094 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2021 | 665 | 0.030 |
Why?
|
| Neutropenia | 1 | 2017 | 200 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 484 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 1059 | 0.030 |
Why?
|
| Female | 3 | 2021 | 66274 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 830 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 3683 | 0.030 |
Why?
|
| Liver | 1 | 2021 | 1733 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 1613 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 1100 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2015 | 795 | 0.030 |
Why?
|
| Male | 2 | 2021 | 60992 | 0.030 |
Why?
|
| Esophageal Neoplasms | 1 | 2017 | 365 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 1559 | 0.030 |
Why?
|
| Cell Line | 1 | 2017 | 2734 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 1696 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3050 | 0.020 |
Why?
|
| Animals | 3 | 2017 | 33999 | 0.020 |
Why?
|
| Mice | 2 | 2017 | 17584 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 8990 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 4334 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 19243 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 29339 | 0.010 |
Why?
|